- 1
- 2
- 3
- ZIRGAN® (ganciclovir ophthalmic gel) 0.15%: A Proven Treatment for Herpetic Keratitis (Dendritic Ulcers)
-
Scleral Expansion Surgery for Presbyopia Again Shows Promise - Barrie Soloway
Improved procedures and encouraging clinical results are creating renewed interest in the use of scleral expansion implants for the treatment of presbyopia.
-
Minimizing the Risk of Corneal Graft Rejection - Victor L. Perez
Although corneal graft rejection rates are the same today as they were two decades ago, the development of new biologic agents promises to improve success with corneal transplants.
-
Reduced-Fluence Laser Treatment for Diabetic Retinopathy - Edward S. Bennett, Karl E. Waite
Reduced-fluence laser may allow for treatment of diabetic retinopathy with less collateral tissue damage.
-
ZIRGAN® (ganciclovir ophthalmic gel) 0.15%: A Proven Treatment for Herpetic Keratitis (Dendritic Ulcers)
For over 15 years, I have used ganciclovir ophthalmic gel 0.15% to treat herpetic keratitis (dendritic ulcers), an option that has now become available in the United States with the introduction of ZIRGAN® (ganciclovir ophthalmic gel) 0.15% (Bausch + Lomb).
Online Editorials
Chris Cooper, OD - An Opportunity
Help Diabetic Patients and Control Healthcare Costs
Print Editorial
Robert C. Campbell, MD, Editor-in-Chief
Although blindness as we use the term is more of a continuum than a discrete state, we tend to believe a person who is blind is one who cannot make use of his visual sense. But a little rethinking may be in order.
Current Digital Edition
